There were 1,720 press releases posted in the last 24 hours and 430,085 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Actinium Pharmaceuticals Announces Dosing of 38th Patient and 25 Percent Enrollment in Iomab-B Pivotal SIERRA Trial

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image